CSIMarket
 


Odonate Therapeutics, Inc.  (ODT)
Other Ticker:  
 
 

ODT's Operating Income Growth by Quarter and Year

Odonate Therapeutics,'s Operating Income results by quarter and year




ODT Operating Income (in millions $) FY 2019 FY 2018 FY 2017 FY 2016
IV Quarter December - -88.40 -2.51 -3.60
III Quarter September -27.76 -0.61 0.47 0.49
II Quarter June -0.57 -1.32 0.53 0.58
I Quarter March -0.54 -16.88 -0.42 0.48
FY   -28.87 -107.21 -1.93 -2.05



ODT Operating Income third quarter 2019 Y/Y Growth Comment
Odonate Therapeutics, Inc. in the third quarter recorded Operating Loss of $ -27.76 millions.

According to the results reported in the third quarter, Odonate Therapeutics, Inc. achieved the best Operating Income growth in Laboratory Analytical Instruments industry. While Odonate Therapeutics, Inc.' s Operating Income no change of % ranks overall at the positon no. in the third quarter.

Explain Operating Income growth


ODT Operating Income ( Y/Y Growth %) 2019
2018 2017 2016
IV Quarter December - - - -
III Quarter September - - -4.08 % 28.95 %
II Quarter June - - -8.62 % -84.28 %
I Quarter March - - - 37.14 %
FY   - - - -

Financial Statements
Odonate Therapeutics,'s third quarter 2019 Operating Income $ -27.76 millions ODT's Income Statement
Odonate Therapeutics,'s third quarter 2018 Operating Income $ -0.61 millions Quarterly ODT's Income Statement
New: More ODT's historic Operating Income Growth >>


ODT Operating Income (Quarter on Quarter Growth %)

2019
2018 2017 2016
IV Quarter December - - - -
III Quarter September - - -11.32 % -15.52 %
II Quarter June - - - 20.83 %
I Quarter March - - - -
FY (Year on Year)   - - - -




Operating Income third quarter 2019 Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #
Healthcare Sector #
Overall #

Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Operating Income third quarter 2019 Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #
Healthcare Sector #
Overall #
Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Operating Income by Quarter for the Fiscal Years 2016, 2017, 2018, 2019

Odonate Therapeutics,'s Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ODT's III. Quarter Q/Q Operating Income Comment
Current results of -27.76 millions by Odonate Therapeutics, Inc. appear even worse if you take a look at -0.57 millions Operating Loss in the second quarter.

Within Laboratory Analytical Instruments industry Odonate Therapeutics, Inc. achieved highest sequential Operating Income growth. While Odonate Therapeutics,'s Operating Income growth quarter on quarter, overall rank is .


Operating Income Q/Q Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ODT's III. Quarter Q/Q Operating Income Comment
Recent results of -27.76 millions by Odonate Therapeutics, Inc. come out even more unfavourable considering the -0.57 millions Operating Loss a quarter before.

Within Laboratory Analytical Instruments industry Odonate Therapeutics, Inc. achieved highest sequential Operating Income growth. While Odonate Therapeutics,'s Operating Income growth quarter on quarter, overall rank is .


Odonate Therapeutics,'s 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Sep 30 2019)
12 Months Ending
(Jun 30 2019)
12 Months Ending
(Mar 31 2019)
12 Months Ending
12 Months Ending
Cumulative Operating Income 12 Months Ending $ -117.28 $ -90.12 $ -90.87 $ 0.00 $ 0.00
Y / Y Operating Income Growth (TTM) - - - - -
Year on Year Operating Income Growth Overall Ranking # # # # #
Seqeuential Operating Income Change (TTM) - - - - -
Seq. Operating Income Growth (TTM) Overall Ranking # # # # #




Cumulative Operating Income growth Comment
Odonate Therapeutics, Inc.' has realized cumulative trailing twelve months Operating Loss of $ -117 millions in the Sep 30 2019 period.
The situation is worsening as the cumulative Operating Loss is inflating from $ -90.12 millions in TTM ending quarter Jun 30 2019 and $ -0.57 millions from the TTM period ending .

Odonate Therapeutics, Inc. achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Operating Income growth Comment
Odonate Therapeutics, Inc.' has realized cumulative trailing twelve months Operating Loss of $ -117 millions in the Sep 30 2019 period.
The situation is getting worse as the cumulative Operating Loss is becoming larger from $ -90.12 millions for the period from Jun 30 2019 to and $ -0.57 millions for the twelve months ending in the quarter a year ago.

Odonate Therapeutics, Inc. achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Operating Income Growth
Laboratory Analytical Instruments Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
ODT's Operating Income Growth Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for ODT's Competitors
Operating Income Growth for Odonate Therapeutics,'s Suppliers
Operating Income Growth for ODT's Customers

You may also want to know
ODT's Annual Growth Rates ODT's Profitability Ratios ODT's Asset Turnover Ratio ODT's Dividend Growth
ODT's Roe ODT's Valuation Ratios ODT's Financial Strength Ratios ODT's Dividend Payout Ratio
ODT's Roa ODT's Inventory Turnover Ratio ODT's Growth Rates ODT's Dividend Comparisons



Companies with similar Operating Income no change for the quarter ending Sep 30 2019 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Sep 30 2019
Icu Medical Inc  3,882.93 %$ 3,882.930 millions


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

SCON's Profile

Stock Price

SCON's Financials

Business Description

Fundamentals

Charts & Quotes

SCON's News

Suppliers

SCON's Competitors

Customers & Markets

Economic Indicators

SCON's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071